Atlas Trials

Unity Biotechnology, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Unity Biotechnology, Inc.

RecordFirmDate
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) (NCT06011798)Unity Biotechnology, Inc.2023-08-23
Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION) (NCT05275205)Unity Biotechnology, Inc.2022-03-02
Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD) (NCT04857996)Unity Biotechnology, Inc.2021-06-25
Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration (NCT04537884)Unity Biotechnology, Inc.2020-10-08
Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo (NCT04349956)Unity Biotechnology, Inc.2020-04-20
A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee (NCT04229225)Unity Biotechnology, Inc.2020-01-23
A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee (NCT04129944)Unity Biotechnology, Inc.2019-10-30
A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee (NCT03513016)Unity Biotechnology, Inc.2018-05-16

Track Unity Biotechnology, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.